iBio
IBIO
IBIO
85 hedge funds and large institutions have $47.6M invested in iBio in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
27% less capital invested
Capital invested by funds: $65.3M → $47.6M (-$17.8M)
48% less call options, than puts
Call options by funds: $1.02M | Put options by funds: $1.97M
Holders
85
Holding in Top 10
–
Calls
$1.02M
Puts
$1.97M
Top Buyers
| 1 | +$784K | |
| 2 | +$560K | |
| 3 | +$192K | |
| 4 |
Renaissance Technologies
New York
|
+$161K |
| 5 |
Goldman Sachs
New York
|
+$156K |
Top Sellers
| 1 | -$277K | |
| 2 | -$257K | |
| 3 | -$191K | |
| 4 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
-$178K |
| 5 |
Squarepoint
New York
|
-$138K |